Search - tctmd.com

Displaying 581 - 600 of 654

Sort: Relevancy | Date

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

Persistent Biomarker Elevations in A-fib Patients Foretell Poor Outcomes

Caitlin E. Cox

May 09, 2014

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

April 23, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Los Pacientes Ancianos con SCA Reciben Menos Tratamiento Intensivo siendo Menores los Beneficios sobre la Supervivencia

Caitlin E. Cox

March 27, 2014

News Daily News

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Caitlin E. Cox

March 27, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

L.A. McKeown

March 20, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

L.A. McKeown

February 06, 2014

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Yael L. Maxwell

August 19, 2013

Advertisement

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Persistent Biomarker Elevations in A-fib Patients Foretell Poor Outcomes

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Los Pacientes Ancianos con SCA Reciben Menos Tratamiento Intensivo siendo Menores los Beneficios sobre la Supervivencia

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content